Mitoxantrone Completed Phase 2 Trials for Relapsed or Refractory Mantle Cell Lymphoma (MCL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00656084Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell